3858 results for «2296»

Filter By

3858 results

TAVI coronary access

22 May 2025 – From EuroPCR 2025

Gain expertise in managing coronary access challenges in TAVI patients. This session discusses when and how to treat coronary lesions in TAVI candidates, strategies to facilitate coronary approach post-TAVI, and long-term outcomes with practical tips through illustrative cases including primary PCI after CoreValve implantation and valve-in-valve...

TAVI coronary access

Challenging left main PCI in NSTEMI patients

22 May 2025 – From EuroPCR 2025

Address the complexities of left main PCI in NSTEMI patients with challenging clinical presentations. This session discusses management of complex left main bifurcation disease, early graft failure guided by imaging and physiology, revascularization strategies for coronary left main occlusion, PCI complications requiring CTO techniques, and acute...

Challenging left main PCI in NSTEMI patients

When angina cannot be cured with stents: what are the remaining options

22 May 2025 – From EuroPCR 2025

Explore therapeutic options for patients with angina refractory to stenting. This session reviews the efficacy and clinical outcomes of coronary sinus (CS) reducer implantation for microvascular dysfunction, factors influencing procedural success, next-generation CS reducer innovations, and the role of aspirin in angina without obstructive coronary disease.

When angina cannot be cured with stents: what are the remaining options

TAVI - Outcomes predictors

22 May 2025 – From EuroPCR 2025

Examine novel predictors of outcomes following TAVI. This session compares a new nutritional risk index against traditional scores for early post-TAVI mortality prediction and evaluates uric acid as a marker for aortic valve calcification and mortality risk in TAVI patients.

TAVI - Outcomes predictors

Retrograde removal of the broken sheath

22 May 2025 – From EuroPCR 2025

This session addresses complex complications during vascular access with a focus on retrograde removal of broken sheaths. Learn to recognize critical signs, manage rare but severe complications including broken guidewires in the radial artery, and explore innovative off-label solutions for challenging scenarios.

Retrograde removal of the broken sheath

TAVI for aortic regurgitation off label

22 May 2025 – From EuroPCR 2025

Explore off-label applications of TAVI for aortic regurgitation in complex clinical scenarios. Topics include TAV-in-SAV with Trilogy valve for severe regurgitation, challenges of transcatheter prosthesis in pure aortic regurgitation, management of surgical valve perforations, and treatment strategies in post-surgical anatomies including degenerative homografts and aortic dissection.

TAVI for aortic regurgitation off label

Acute complications during distal left main PCI - Part 3

22 May 2025 – From EuroPCR 2025

This session highlights acute complications during distal left main PCI. It presents cautionary cases of incorrect left main stenting, catastrophic left main V stenting outcomes, unprotected left main thrombosis, and survival strategies when new technologies fail unexpectedly.

Acute complications during distal left main PCI - Part 3

Peripheral interventions: the hidden key for complications

22 May 2025 – From EuroPCR 2025

Uncover the critical role of peripheral interventions in managing complications. This session shares case stories of lost stents, unusual TAVI access complications, percutaneous removal of misplaced devices, revascularisation of iatrogenic pseudoaneurysms, and challenges when multiple closure devices are insufficient.

Peripheral interventions: the hidden key for complications

Refractory heart failure: combining oral therapy and device is key

21 May 2025 – From EuroPCR 2025

Address refractory heart failure management through combined oral therapy and device interventions. This session helps identify patients needing treatment escalation, reviews contemporary cardiovascular intervention indications, and emphasizes achieving optimal synergy between pharmacologic and device-based therapies through clinical case discussions.

Refractory heart failure: combining oral therapy and device is key

PCI for complex bifurcation disease - LIVE Case

23 May 2025 – From EuroPCR 2025

A 60-year-old male patient presented with an inferior STEMI one month ago, which was treated with RCA and LCx PCI. He was referred for LAD/diagonal PCI. The LV function was reduced (EF 45 %). The team performed a DK crush PCI, guided by IVUS.

LIVE Educational Case...

PCI for complex bifurcation disease - LIVE Case

PCR meets China: great innovations and novel trials

21 May 2025 – From EuroPCR 2025

Join this session to explore innovative coronary and valvular device developments originating from China. Learn about the clinical relevance and global impact of these domestic innovations, and engage in knowledge exchange with Chinese colleagues, celebrating longstanding collaboration in cardiology.

PCR meets China: great innovations and novel trials

PCR's Got Talent Award, best abstract & best case Awards

23 May 2025 – From EuroPCR 2025

Celebrate the outstanding achievements recognized at PCR's Got Talent Award, highlighting the best abstracts and cases from the conference, showcasing innovation and excellence in interventional cardiology.

PCR's Got Talent Award, best abstract & best case Awards

Welcome to EuroPCR 2025

20 May 2025 – From EuroPCR 2025

Welcome to EuroPCR 2025, the premier event for interventional cardiology innovation and education, where leaders and professionals gather to shape the future of cardiovascular care.

Welcome to EuroPCR 2025

EAPCI Fellowship Grant Awards

21 May 2025 – From EuroPCR 2025

Celebrate the achievements of emerging cardiology leaders with the EAPCI Fellowship Grant Awards session. This presentation highlights the awarded fellows' contributions and the impact of fellowship support on advancing interventional cardiology research and clinical practice.

EAPCI Fellowship Grant Awards

EuroPCR 2025 Closing Ceremony

23 May 2025 – From EuroPCR 2025

Conclude your conference experience with the EuroPCR 2025 Closing Ceremony, celebrating the achievements, innovations, and advancements presented throughout the event, and setting the stage for future developments in interventional cardiology.

EuroPCR 2025 Closing Ceremony

Jon DeHaan Foundation Award & Michele Pighi Young Investigator Award

21 May 2025 – From EuroPCR 2025

Celebrate innovation and research excellence in interventional cardiology with the Jon DeHaan Foundation Award and Michele Pighi Young Investigator Award session. This session highlights groundbreaking work and emerging talent shaping the future of cardiovascular interventions.

Jon DeHaan Foundation Award & Michele Pighi Young Investigator Award

Andreas Grüntzig Ethica Award

22 May 2025 – From EuroPCR 2025

Recognize excellence in interventional cardiology with the prestigious Andreas Grüntzig Ethica Award. This session honors outstanding contributions and ethical standards that advance the field and improve patient care worldwide.

Andreas Grüntzig Ethica Award

EuroIntervention 20th anniversary and annual editorial meeting – All EuroPCR participants welcome

22 May 2025 – From EuroPCR 2025

Mark the 20th anniversary of EuroIntervention with this special annual editorial meeting open to all EuroPCR participants. Reflect on the journal's achievements, discuss future directions, and engage with leaders in interventional cardiology to shape the evolving landscape of cardiovascular research and practice.

EuroIntervention 20th anniversary and annual editorial meeting – All EuroPCR participants welcome

Predictors outcome after tricuspid TEER: is there a perfect tool

22 May 2025 – From EuroPCR 2025

Examine predictors of outcome following tricuspid transcatheter edge-to-edge repair (TEER) in this focused session. Review meta-analyses on TEER efficacy, survival benefits in high-risk patients from the EuroTR registry, and prognostic value of MELD?XI score from the TRISPA registry. Learn about TRI.Fr eligibility criteria and validation of...

Predictors outcome after tricuspid TEER: is there a perfect tool

Is DCB a new valid option for coronary revascularisation?

22 May 2025 – From EuroPCR 2025

This session provides an in-depth evaluation of drug-coated balloons (DCB) as a valid option for coronary revascularisation. Topics include two-year follow-up comparisons between paclitaxel and sirolimus-coated balloons, clinical outcomes after bailout stenting post-DCB angioplasty, meta-analyses contrasting DCB and DES for large native coronary artery disease, and...

Is DCB a new valid option for coronary revascularisation?
Didn’t find what you were looking for?